Still A Ways To Go
Treatment of serious mental illnesses has improved over the course of time—but there is still a long way to go. For consumers with schizophrenia, only 14.3% received care that could be considered consistent with evidence-based treatment recommendations. For consumers participating in treatment, 25% to 60% are adherent with the recommended treatment plan and 80% to 90% of consumers treated for schizophrenia experience a relapse.
One byproduct of the current state of treatment is higher total health care costs. Consumers with schizophrenia …